#biotech - Techseriesinsight

October 16, 2025
PRNewswire
Biotechnology, News

Philadelphia Biotech, LIV Process Unveils Breakthrough “Microbial Visualization” Technology

As infectious disease leaders gather in Atlanta for IDWeek 2025 (October 19–22), Philadelphia-based biotech, LIV Process is shining a light on one of healthcare’s most persistent challenges: healthcare-associated infections (HAIs). LIV Process,...

July 29, 2025
PRNewswire
Biotechnology, News

Hope in New Alzheimer’s Blood Test

TrilliumBiO, a leader in biomarker discovery and precision diagnostics, today announced a strategic collaboration with T-NeuroDx, a pioneering diagnostics company dedicated to developing innovative solutions for detecting neurodegenerative diseases,...

July 21, 2025
PRNewswire
Biotechnology, News

Synthego Announces Successful Close of Acquisition by Perceptive Advisors

Synthego, a leading provider of CRISPR solutions, today announced the successful closing of the acquisition of substantially all of its assets by funds managed by Perceptive Advisors, a leading...

July 10, 2025
Business Wire
Biotechnology, Healthcare, News

Sinovac’s New Board Holds First Meeting, Elects Andrew Y. Yan as Chairman

Sinovac Biotech Ltd. (NASDAQ: SVA) (SINOVAC or the Company), a leading provider of biopharmaceutical products in China, today announced the new board of directors of the Company (the Board), comprising Mr. Simon...

July 1, 2025
Business Wire
Biotechnology, Healthcare, News

Vertex’s ALYFTREK® Approved by European Commission

Vertex Pharmaceuticals (Nasdaq: VRTX) today announced that the European Commission has granted approval for ALYFTREK® (deutivacaftor/tezacaftor/vanzacaftor)for the treatment of people with cystic fibrosis (CF) ages 6 years and older who have...

Pipette adding liquid to petri dish in lab with test tubes behind.

June 30, 2025
PRNewswire
Healthcare, News

Oncolytics Biotech Appoints Former Ambrx Executive as Chief Business Officer to Drive Business Development Strategy

Oncolytics Biotech Inc. (NASDAQ: ONCY) (TSX: ONC), a leading clinical-stage company specializing in immunotherapy for oncology, today announced the appointment of Andrew Aromando as Chief Business Officer. Mr. Aromando most recently served as...

June 24, 2025
PRNewswire
Biotechnology, Healthcare, News

Bio-Techne and USP Drive Breakthroughs in Antibody and Gene Therapies

Bio-Techne Corporation (NASDAQ: TECH) today announced a distribution agreement with the U.S. Pharmacopeia (USP) that enables the Company to sell USP monoclonal antibody (mAb) and recombinant adeno-associated virus (AAV) reference...

May 27, 2025
PRNewswire
Biotechnology

KAHR Bio Announces Oral Presentation of Phase 2 Study of DSP107 in Combination with anti-PD-L1 in Colorectal Cancer at 2025 ASCO Annual Meeting

KAHR, a clinical-stage biotech company developing DSP107, a first-in-class bi-specific 4-1BB T-cell engager that activates innate and adaptive immunity to treat solid tumors, today announced that positive results from...

May 23, 2025
PRNewswire
Healthcare

Oncolytics Biotech® to Present New Clinical Trial Data at ASCO Showing Pelareorep’s Unique Immune Activation Capabilities

Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC), a leading clinical-stage company specializing in immunotherapy for oncology, today announced new data from the Phase I/II GOBLET clinical trial in a poster presentation...

May 21, 2025
PRNewswire
Biotechnology

SK bioscience Wins Patent Lawsuit Against Pfizer Over Pneumococcal Vaccine

SK bioscience, a global innovative vaccine and biotech company committed to promoting human health from prevention to cure, today announced that it the Supreme Court of Korea has ruled...